Quantcast
Last updated on April 19, 2014 at 9:20 EDT

Latest Thoratec Corporation Stories

2014-04-14 16:25:55

PLEASANTON, Calif., April 14, 2014 /PRNewswire/ -- Thoratec Corporation (NASDAQ: THOR), a world leader in device-based mechanical circulatory support therapies to save, support and restore failing hearts, today announced that it will report its operating results for the first quarter of fiscal year 2014 on Tuesday, May 6. The company will hold a conference call to discuss its financial results and operating activities, open to all interested parties, at 1:30 p.m., Pacific Daylight...

2014-03-17 16:28:56

PLEASANTON, Calif., March 17, 2014 /PRNewswire/ -- On March 4, 2014, Thoratec Corporation initiated a voluntary worldwide Medical Device Correction in order to update its labeling and training materials for the HeartMate II(®) LVAS Pocket System Controller (the "Pocket Controller"). The following information is provided as a reinforcement of the initial release. Failure to completely connect the driveline during the process of exchanging Pocket System Controllers has resulted in serious...

2014-03-04 16:26:01

PLEASANTON, Calif., March 4, 2014 /PRNewswire/ -- On March 4, 2014, Thoratec Corporation initiated a voluntary worldwide Medical Device Correction in order to update its labeling and training materials for the HeartMate II(®) LVAS Pocket System Controller (the "Pocket Controller"). This safety advisory is being issued because some patients and caregivers have experienced difficulties with the process of changing from a primary system controller to their backup system controller. These...

2014-02-26 12:26:13

PLEASANTON, Calif., Feb. 26, 2014 /PRNewswire/ -- Thoratec Corporation (NASDAQ: THOR), a world leader in device-based mechanical circulatory support therapies to save, support and restore failing hearts, said today it will be participating in two upcoming investor conferences. On Monday, March 3, the company will participate in the Raymond James 35(th) Annual Institutional Investors Conference. Taylor C. Harris, Vice President and Chief Financial Officer, will provide an update on...

2014-02-21 16:23:00

NEW YORK, Feb. 21, 2014 /PRNewswire/ -- Pomerantz LLP has filed a class action lawsuit against Thoratec Corporation ("Thoratec" or the "Company")(NASDAQ: THOR) and certain of its officers. The class action, filed in United States District Court, Northern District of California, and docketed under 14-cv-00360, is on behalf of a class consisting of all persons or entities who purchased or otherwise acquired Thoratec securities between April 29, 2010 and November 27, 2013 both dates...

2014-02-04 16:28:56

- Revenue of $128.2 million for the fourth quarter of 2013 PLEASANTON, Calif., Feb. 4, 2014 /PRNewswire/ -- Thoratec Corporation (NASDAQ: THOR), a world leader in device-based mechanical circulatory support (MCS) therapies to save, support and restore failing hearts, today reported its financial results for the fourth quarter of 2013. "We were pleased with our financial performance for the fourth quarter and full year, supported by robust growth in the worldwide market for...

2014-01-31 12:25:45

PLEASANTON, Calif., Jan. 31, 2014 /PRNewswire/ -- Thoratec Corporation (NASDAQ: THOR), a world leader in device-based mechanical circulatory support therapies to save, support and restore failing hearts, said today it will be participating in the Leerink Global Healthcare Conference on Wednesday, February 12. Taylor C. Harris, Vice President and Chief Financial Officer, will provide an update on the company, beginning at 3:05 p.m., Eastern Standard Time (12:05 p.m., Pacific Standard...

2014-01-23 08:31:02

PLEASANTON, Calif., Jan. 23, 2014 /PRNewswire/ -- Thoratec Corporation (NASDAQ: THOR), a world leader in device-based mechanical circulatory support therapies to save, support and restore failing hearts, today announced that it will report its operating results for the fourth quarter of fiscal year 2013 on Tuesday, February 4. The company will hold a conference call to discuss its financial results and operating activities, open to all interested parties, at 1:30 p.m., Pacific...

2013-12-19 12:29:56

PLEASANTON, Calif., Dec. 19, 2013 /PRNewswire/ -- Thoratec Corporation (NASDAQ: THOR), a world leader in device-based mechanical circulatory support therapies to save, support and restore failing hearts, said today it will be participating in the 32(nd) Annual J.P. Morgan Healthcare Conference on Monday, January 13, 2014. Gary F. Burbach, President and Chief Executive Officer, will provide an update on the company, beginning at 8:00 a.m., Pacific Standard Time (11:00 a.m., Eastern...

2013-12-09 08:30:59

PLEASANTON, Calif., Dec. 9, 2013 /PRNewswire/ -- Thoratec Corporation (NASDAQ: THOR), a world leader in device-based mechanical circulatory support therapies to save, support and restore failing hearts, announced today that its Board of Directors has authorized the repurchase of up to $200 million of the company's shares of common stock effective through the end of 2015. The company's previous share repurchase authorization will expire at the end of 2013. "This authorization...